For a drug to cross the skin, it must pass through the lipid-rich stratum corneum and then move through water-based tissue layers. Learn why balancing water and lipid solubility supports percutaneous diffusion—and why either property alone can limit absorption.

Multiple Choice

Which property best enables percutaneous diffusion?

Percutaneous diffusion relies on the drug moving through both lipophilic barrier regions and aqueous tissue environments. The outer skin layer, the stratum corneum, is lipid-rich, so the drug must partition into and diffuse through fats. At the same time, the underlying viable epidermis and dermis are more aqueous, so the drug also needs enough solubility in water to move through those spaces. A compound with both high water solubility and high lipid solubility can readily partition into the skin from a vehicle, traverse the lipid barrier, and then diffuse through the aqueous layers into systemic circulation. If a drug is only lipid-soluble, it may have trouble dissolving in the aqueous pathways; if it’s only water-soluble, it may not partition well into the lipid-rich stratum corneum. Therefore, having both properties makes percutaneous diffusion most efficient.

A medicine applied to the skin faces a journey through two very different environments. First comes the outer barrier, rich in lipids—fats and fat-like substances. Beneath it lie living skin layers with more water. For a drug to cross the skin effectively, it needs to interact with both. That is why a useful balance of lipid and water solubility matters so much in percutaneous diffusion.

Percutaneous diffusion is the movement of a substance through the skin. The word percutaneous simply means “through the skin,” while diffusion describes the movement of molecules from an area of higher concentration to one of lower concentration. Together, the terms describe how a drug may travel from a cream, gel, patch, or other product into and across the skin.

The route sounds simple enough. In reality, skin is a layered, selective barrier—not a sponge that lets every dissolved substance pass. A drug must leave its formulation, enter the skin, move through its different layers, and, if systemic delivery is intended, reach the blood vessels below. Each step favors somewhat different chemical properties.

The first hurdle is a fatty one

The skin’s outermost layer, the stratum corneum, is the main obstacle to most substances trying to cross the skin. It consists of flattened, dead cells held within a matrix rich in lipids. A common image is bricks and mortar: the cells are the bricks, and the surrounding fats are the mortar. This arrangement helps the body retain water and keep irritants and germs out. It also makes the layer hard for many medicines to cross.

Because this outer barrier contains plenty of lipids, a drug needs some affinity for fats to enter and move through it. A very water-soluble molecule may dissolve well in an aqueous cream, but it may not readily leave that environment and partition into the stratum corneum. It is a bit like trying to move from a rainy sidewalk into an oil-filled passageway: the molecule needs the right chemical “feel” to cross the boundary.

This movement between environments is called partitioning. A drug partitions into a layer when it leaves one surrounding material and becomes more concentrated in another. For topical delivery, partitioning from the product into the outer skin is a key early step. If that step goes poorly, the drug may remain in the formulation rather than enter the skin.

But the trip doesn’t end in the outer layer

Below the stratum corneum, the viable epidermis and dermis contain more water. The dermis also holds blood vessels, connective tissue, and other structures. A drug moving deeper must cope with these more aqueous surroundings, not just the lipid-rich outer barrier.

That’s why a drug with strong lipid solubility but very poor water solubility can run into trouble. It may enter the fatty outer layer, yet move poorly through the water-rich tissue beneath it. It can also become retained in the stratum corneum instead of continuing onward. Getting into the skin and getting through the skin are related, but they are not the same thing.

The reverse can happen with a highly water-soluble drug. It may travel well through water-based parts of the formulation or tissue, but struggle to enter the lipid-rich outer barrier in the first place. In both cases, one useful trait is missing. Efficient passage generally calls for enough affinity for both lipid and water environments.

A balance, not a simple “more is better”

It’s tempting to think that a drug with very high solubility in both water and lipids must always cross the skin quickly. The real picture is more nuanced. The drug needs a workable balance: enough lipid affinity to enter and move through the stratum corneum, and enough water solubility to continue through the living layers.

Solubility also isn’t the only factor. A drug may dissolve in a material without moving out of it easily. For example, if it is held very strongly by the vehicle—the cream, gel, or other carrier—it may not readily transfer into the skin. The drug’s concentration in the formulation, its molecular size, and its chemical form can all affect how much gets across.

The vehicle matters because it sets the conditions at the skin’s surface. A drug in an oil-based product may behave differently from the same drug in a water-based gel. Some formulations help a drug partition into the stratum corneum; others keep it more comfortable or stable but release it more slowly. The vehicle is not merely packaging. It is part of the delivery system.

What else shapes skin absorption?

The skin itself is not a fixed wall. Its condition, thickness, and location can change how readily a substance passes through. Skin on the sole of the foot, for instance, is much thicker than skin on the eyelid. A damaged or irritated barrier may allow more material through than intact skin, which is one reason topical products should be used as directed.

Molecular size also plays a role. Smaller molecules often cross the skin more readily than larger ones, all else being equal. Electrical charge can matter too: a molecule’s ionization state affects how it behaves in water and lipids. For many drugs, pH influences that state, so the formulation may affect skin entry as well as comfort and stability.

There’s also the matter of concentration. Diffusion is driven in part by a concentration gradient—the difference in concentration between one area and another. A greater difference can encourage movement, though it doesn’t erase the skin’s other barriers. Think of a crowded train platform: adding more people at one end may increase the flow toward an emptier area, but the number of doors and the width of the passage still matter.

Why the skin’s barrier is both helpful and challenging

The same structure that makes transdermal delivery difficult is essential to health. The stratum corneum limits water loss and blocks many outside substances. Without it, the body would be far more exposed to its surroundings. In drug delivery, that protective job becomes a design challenge: a product must encourage enough passage for its intended effect without treating the skin as an open route.

Not every medicine is suited to delivery through intact skin. A drug must have properties that support movement through several different environments, and the formulation must release it in a useful way. Some products are designed to act mainly on the skin’s surface or within nearby tissue; others aim to carry a drug into systemic circulation. Those goals call for different delivery strategies.

The useful takeaway

Percutaneous diffusion depends on more than a single chemical trait, but the skin’s changing composition makes the central idea clear. A drug first encounters a lipid-rich barrier, then more water-rich living tissue. It therefore needs a balance of lipid and water solubility to move through both kinds of environment.

Too little lipid affinity can make entry into the stratum corneum difficult. Too little water solubility can slow movement through deeper, aqueous layers. Formulation, molecular size, concentration, and skin condition add further layers to the story. Still, the core principle holds: skin delivery works best when a drug can make the transition from the product to the fatty outer barrier and then onward through tissue that is largely water-based.